BRCA1 and cancer: In this case, dCas9:TET1 increased BRCA1 expression and inhibited the proliferation of a cancer cell line, highlighting the therapeutic potential of epigenome editing to reduce hypermethylation in promoters of tumor suppressor genes, which is one of the hallmarks of cancer [146].